Vijaya Diagno Peer Comparison
NSE: VIJAYA | BSE: 543350
₹1,451.60
₹29.40
(2.07%)
As on 06-Oct-2026 13:04IST
Market cap
₹14,763 Cr
Revenue (TTM)
₹857 Cr
P/E Ratio
78.7
P/B Ratio
14.7
Div. Yield
0.1 %
Edit
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
14,763 | 35,021 | 33,599 | 29,377 | 11,315 |
Revenue (₹ Cr) |
857 | 4,683 | 2,891 | 4,213 | 1,710 |
Net Profit (₹ Cr) |
187.49 | 552.34 | 546.30 | 190.80 | 202.82 |
Net Margin (%) |
21.32 | 11.55 | 18.23 | 4.49 | 11.70 |
RoE (%) |
20.58 | 14.93 | 23.03 | 9.45 | 14.13 |
Price to Earnings |
78.74 | 62.97 | 62.00 | 143.80 | 56.12 |
Price-To-Book |
14.66 | 8.52 | 12.86 | 7.76 | 7.26 |
Income Statement (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Operating Revenue
|
857.13 | 4,683.37 | 2,890.80 | 4,212.50 | 1,710.00 |
|
Total Income
|
879.41 | 4,783.78 | 2,995.90 | 4,248.00 | 1,733.17 |
|
Total Expenditure
|
495.19 | 3,704.62 | 2,053.10 | 3,379.70 | 1,287.72 |
|
EBITDA
|
361.94 | 978.75 | 837.70 | 832.80 | 422.28 |
|
Depreciation
|
96.06 | 246.41 | 171.60 | 330.60 | 135.28 |
|
EBIT
|
265.89 | 732.34 | 666.10 | 502.20 | 287.00 |
|
Interest
|
36.75 | 92.01 | 24.40 | 253.30 | 25.53 |
|
Other Income
|
22.28 | 100.41 | 105.10 | 35.50 | 23.17 |
|
Exceptional Items
|
0.00 | -20.61 | -30.10 | -11.20 | -8.99 |
|
Profit before Tax
|
251.42 | 720.14 | 716.70 | 273.20 | 275.66 |
|
Provision for Tax
|
63.93 | 167.80 | 170.40 | 82.40 | 72.84 |
|
Profit after Tax
|
187.49 | 552.34 | 546.30 | 190.80 | 202.82 |
Liabilities (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
957.15 | 3,961.57 | 2,508.20 | 2,247.40 | 1,513.16 |
|
Minority Interest
|
0.00 | 3.84 | -4.40 | 9.90 | -1.20 |
|
Non-Current Liabilities
|
426.03 | 1,293.60 | 154.00 | 3,961.30 | 279.48 |
|
Current Liabilities
|
123.87 | 627.13 | 450.70 | 1,238.90 | 334.02 |
|
Total Liabilities
|
1,507.05 | 5,905.00 | 3,139.97 | 7,690.70 | 2,524.76 |
Assets (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
737.24 | 3,128.95 | 1,176.30 | 5,416.90 | 1,415.30 |
|
Current Assets
|
321.90 | 1,674.92 | 1,566.60 | 937.40 | 468.61 |
|
Total Assets
|
1,507.05 | 5,905.00 | 3,139.97 | 7,690.70 | 2,524.76 |
|
Total Debt*
|
0.00 | 631.08 | 0.00 | 3,244.00 | 18.73 |
|
Net Current Assets
|
198.03 | 1,047.79 | 1,115.90 | -301.50 | 134.59 |
|
Contingent Liabilities
|
0.13 | 100.01 | 16.76 | 81.10 | 10.08 |
Cashflow (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
270.59 | 714.39 | 635.61 | 510.80 | 350.70 |
|
Cash Flow from Investing Activities
|
-174.22 | -1,089.11 | -421.86 | -1,451.70 | -223.13 |
|
Cash from Financing Activities
|
-69.49 | 271.85 | -263.57 | 940.30 | -115.29 |
|
Net Cash Inflow / Outflow
|
26.88 | -102.87 | -49.83 | -0.60 | 12.28 |
Ratios
Profitability Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
ROCE (%)
|
30.28 | 19.38 | 29.56 | 11.51 | 20.03 |
|
ROE (%)
|
20.58 | 14.93 | 23.03 | 9.45 | 14.13 |
|
ROA (%)
|
13.49 | 10.35 | 18.64 | 2.83 | 10.13 |
|
EBIT Margin (%)
|
31.02 | 15.64 | 23.04 | 11.92 | 16.78 |
|
Net Margin (%)
|
21.32 | 11.55 | 18.23 | 4.49 | 11.70 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
20.18 | 21.27 | 14.29 | 30.90 | 21.80 |
|
EBIT Growth (%)
|
26.22 | 0.94 | 15.64 | -16.88 | 43.53 |
|
Net Profit Growth (%)
|
24.27 | 3.43 | 5.38 | -52.81 | 32.87 |
|
EPS Growth (%)
|
23.44 | 2.70 | -30.51 | -42.60 | -16.64 |
|
Book Value Growth (%)
|
21.86 | 16.51 | 15.41 | 5.13 | 13.54 |
Valuation Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Price / Earnings
|
78.04 | 62.53 | 46.22 | 132.85 | 22.56 |
|
Price / Book Value
|
14.55 | 8.71 | 12.66 | 7.79 | 7.39 |
|
Dividend Yield (%)
|
0.14 | 0.04 | 1.04 | 0.00 | 0.90 |
|
EV/EBITDA
|
39.72 | 36.07 | 37.90 | 39.19 | 26.83 |
|
Market Cap (₹ Cr)
|
8,864.05 | 25,841.07 | 22,015.15 | 24,901.98 | 8,992.90 |
Solvency Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 0.00 | 1.19 | 0.00 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.15 | 0.01 |
|
Current Ratio
|
2.60 | 2.67 | 3.48 | 0.76 | 1.40 |
|
Quick Ratio
|
2.56 | 2.54 | 3.38 | 0.68 | 1.27 |
|
Interest Coverage
|
7.84 | 8.83 | 30.37 | 2.08 | 11.80 |
Operating Efficiency Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
2.43 | 8.78 | 3.83 | 13.16 | 9.96 |
|
Asset Turnover
|
0.62 | 0.88 | 0.99 | 0.62 | 0.85 |
|
Receivable days
|
7.98 | 29.09 | 13.13 | 44.38 | 35.29 |
|
Inventory Days
|
2.20 | 6.05 | 5.28 | 7.52 | 10.35 |
|
Payable days
|
136.27 | 80.04 | 118.67 | 133.54 | 143.56 |
|
Cash Conversion Cycle
|
-126.08 | -44.90 | -100.26 | -81.64 | -97.92 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
